Fusion Pharmaceuticals Inc. Operating Lease, Payments
Fusion Pharmaceuticals Inc. reported Operating Lease, Payments of $973.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. operating lease, payments for the quarter ending 2024-03-31 was $973.00K, a 122.65% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, payments for the quarter ending 2023-12-31 was $5.01M, a 1190.72% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, payments for the quarter ending 2023-09-30 was $574.00K, a 64.00% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, payments for the quarter ending 2023-06-30 was $572.00K, a 55.86% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating lease, payments for fiscal 2023 was $6.59M, a 349.59% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. operating lease, payments for fiscal 2022 was $1.47M, a 27.92% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. operating lease, payments for fiscal 2021 was $1.15M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-03-31 | $973.00K 10-Q · filed 2024-05-07 | $5.98M derived: sum of 2 quarters · filed 2024-05-07 | $6.55M derived: sum of 3 quarters · filed 2024-05-07 | $7.13M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $5.58M derived: sum of 2 quarters · filed 2024-03-20 | $6.15M derived: sum of 3 quarters · filed 2024-03-20 | $6.59M 10-K · filed 2024-03-20 |
| 2023-09-30 | $574.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.15M derived: sum of 2 quarters · filed 2023-11-07 | $1.58M 10-Q · filed 2023-11-07 | $1.97M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $572.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.01M 10-Q · filed 2023-08-08 | $1.40M derived: sum of 3 quarters · filed 2023-08-08 | $1.75M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $437.00K 10-Q · filed 2023-05-11 | $825.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.18M derived: sum of 3 quarters · filed 2023-05-11 | $1.54M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $738.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.10M derived: sum of 3 quarters · filed 2023-03-16 | $1.47M 10-K · filed 2023-03-16 |
| 2022-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $717.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.08M 10-Q · filed 2022-11-08 | $1.37M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $728.00K 10-Q · filed 2022-08-09 | $1.02M derived: sum of 3 quarters · filed 2022-08-09 | $1.30M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $361.00K 10-Q · filed 2022-05-10 | $649.00K derived: sum of 2 quarters · filed 2022-05-10 | $938.00K derived: sum of 3 quarters · filed 2022-05-10 | $1.23M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $577.00K derived: sum of 2 quarters · filed 2022-03-17 | $866.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.15M 10-K · filed 2022-03-17 |
| 2021-09-30 | $289.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $578.00K derived: sum of 2 quarters · filed 2021-11-09 | $858.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $289.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $569.00K 10-Q · filed 2021-08-10 | ||
| 2021-03-31 | $280.00K 10-Q · filed 2021-05-11 |